GHI le Raincy Montfermeil
Welcome,         Profile    Billing    Logout  
 0 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DELLAL, Azeddine
ARIES, NCT06757426: Prospective Observational Study Evaluating the Safety and Efficacy of Immunomodulatory Therapies in Refractory Inflammatory and Autoimmune Diseases

Not yet recruiting
N/A
80
Europe
Groupe français d'étude des Maladies Inflammatoires de loeil
Autoimmune Diseases, Inflammatory Diseases
07/25
07/28
GOLDRAN-TOLEDANO, Dany
FAME, NCT05461521: Improving FAMily Members' Experience in the ICU

Completed
N/A
1346
Europe, RoW
Family members of patients admitted to the ICU, Health care professionals, Patients
Nantes University Hospital, Assistance Publique - Hôpitaux de Paris, Assistance Publique Hopitaux De Marseille
Stress Disorders, Post-Traumatic, Family Members
01/24
09/24
DELLAL, Azzedine
SAPHIR, NCT05598684: : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases

Recruiting
N/A
600
Europe, RoW
Fresenius Kabi, France
Crohn Disease, Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis
09/25
12/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DELLAL, Azeddine
ARIES, NCT06757426: Prospective Observational Study Evaluating the Safety and Efficacy of Immunomodulatory Therapies in Refractory Inflammatory and Autoimmune Diseases

Not yet recruiting
N/A
80
Europe
Groupe français d'étude des Maladies Inflammatoires de loeil
Autoimmune Diseases, Inflammatory Diseases
07/25
07/28
GOLDRAN-TOLEDANO, Dany
FAME, NCT05461521: Improving FAMily Members' Experience in the ICU

Completed
N/A
1346
Europe, RoW
Family members of patients admitted to the ICU, Health care professionals, Patients
Nantes University Hospital, Assistance Publique - Hôpitaux de Paris, Assistance Publique Hopitaux De Marseille
Stress Disorders, Post-Traumatic, Family Members
01/24
09/24
DELLAL, Azzedine
SAPHIR, NCT05598684: : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases

Recruiting
N/A
600
Europe, RoW
Fresenius Kabi, France
Crohn Disease, Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis
09/25
12/25

Download Options